← FDA DRUG APPROVALS

FDA ANDA · ANDA208231

ARSENIC TRIOXIDE

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA208231
TYPE
ANDA
ORIGINAL APPROVAL
2018-08-31
LATEST ACTION
2023-10-11
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ARSENIC TRIOXIDEPrescription
ARSENIC TRIOXIDE 1MG/ML · INJECTABLE · INJECTION

Approval history

2023-10-11Labeling · Supplement 2 · standardAP
2023-10-11Labeling · Supplement 3 · standardAP
2018-08-31UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →